1. Home
  2. MDRR vs VNRX Comparison

MDRR vs VNRX Comparison

Compare MDRR & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MDRR

Medalist Diversified REIT Inc.

HOLD

Current Price

$10.23

Market Cap

18.2M

Sector

Real Estate

ML Signal

HOLD

Logo VolitionRX Limited

VNRX

VolitionRX Limited

HOLD

Current Price

$3.12

Market Cap

18.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MDRR
VNRX
Founded
2015
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.2M
18.9M
IPO Year
N/A
2012

Fundamental Metrics

Financial Performance
Metric
MDRR
VNRX
Price
$10.23
$3.12
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$1.67
AVG Volume (30 Days)
944.0
514.4K
Earning Date
03-02-2026
05-12-2026
Dividend Yield
2.43%
N/A
EPS Growth
N/A
38.00
EPS
N/A
N/A
Revenue
N/A
$1,727,384.00
Revenue This Year
N/A
$355.66
Revenue Next Year
N/A
$849.08
P/E Ratio
N/A
N/A
Revenue Growth
N/A
40.04
52 Week Low
$9.55
$0.13
52 Week High
$14.52
$2.89

Technical Indicators

Market Signals
Indicator
MDRR
VNRX
Relative Strength Index (RSI) 32.18 77.26
Support Level $10.13 $0.22
Resistance Level $12.45 N/A
Average True Range (ATR) 0.19 0.28
MACD -0.06 0.01
Stochastic Oscillator 32.69 94.09

Price Performance

Historical Comparison
MDRR
VNRX

About MDRR Medalist Diversified REIT Inc.

Medalist Diversified Inc owns ten investment properties comprised of three retail properties, three flex/industrial properties, and four STNL properties, including the Tesla Pensacola Property. Through its subsidiary, the company sponsors Delaware Statutory Trusts (DSTs) that provide accredited investors access to institutional-quality real estate with the transparency and governance of a public company. The company has three reportable segments, consisting of retail center properties, flex center properties, and STNL properties. The company generates the majority of its revenue from the Retail Center Property.

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on diagnostics and monitoring.

Share on Social Networks: